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Aims: Animal models have been used to show that there are critical molecular
mechanisms that can be activated to induce myocardial repair at specific times in
development. For example, specific miRNAs are critical for regulating the response
to myocardial infarction (MI) and improving the response to injury. Manipulating these
miRNAs in small animal models provides beneficial effects post-MI; however it is not
known if these miRNAs are regulated similarly in large mammals. Studying a large animal
where the timing of heart development in relation to birth is similar to humans may
provide insights to better understand the capacity to repair a developing mammalian
heart and its application to the adult heart.
Methods: We used a sheep model of MI that included permanent ligation of the
left anterior descending (LAD) coronary artery. Surgery was performed on fetuses (at
105 days gestation when all cardiomyocytes are mononucleated and proliferative) and
adolescent sheep (at 6 months of age when all cardiomyocytes contribute to heart
growth by hypertrophy). A microarray was utilized to determine the expression of known
miRNAs within the damaged and undamaged tissue regions in fetal and adolescent
hearts after MI.
Results: 73 miRNAs were up-regulated and 58 miRNAs were down-regulated
significantly within the fetal infarct compared to remote cardiac samples. From
adolescent hearts 69 non-redundant miRNAs were up-regulated and 63 miRNAs were
down-regulated significantly in the infarct area compared to remote samples. Opposite
differential expression profiles of 10 miRNAs within tissue regions (Infarct area, Border
zone and Remote area of the left ventricle) occurred between the fetuses and adolescent
sheep. These included miR-558 and miR-1538, which when suppressed using LNA
anti-miRNAs in cell culture, increased cardiomyoblast proliferation.
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Conclusion: There were significant differences in miRNA responses in fetal and
adolescent sheep hearts following a MI, suggesting that the modulation of novel
miRNA expression may have therapeutic potential, by promoting proliferation or repair
in a damaged heart.
Keywords: cardiac, regeneration, fetus, myocardial infarction, miRNA
INTRODUCTION
Cardiovascular disease is one of the largest causes of morbidity
and mortality worldwide, and is due to the limited capacity
to repair human adult heart tissue after myocardial damage
(Wong et al., 2012; Benjamin et al., 2017; Wilkins et al.,
2017). The lack of regenerative potential is presumed to be
the result of cardiomyocyte quiescence, and although there is
some evidence for cardiomyocyte proliferation in adult humans,
this is insufficient for regeneration or repair (Bergmann et al.,
2009; Barnett and van den Hoff, 2011). Current treatments after
acute coronary syndromes address the ongoing symptoms and
attempt to prevent re-infarction (Dalal et al., 2015). The current
lack of effective treatments for repairing heart tissue damage
necessitate new approaches to promote the regeneration of adult
human heart tissue.
The adult zebrafish, neonatal mouse and fetal sheep have a
remarkable ability to regenerate heart tissue after myocardial
infarction (MI) (Herdrich et al., 2010; Jopling et al., 2010;
Porrello et al., 2011). By studying the transitional period
of cardiomyocyte proliferation to quiescence in zebrafish
and mouse models, several promising target miRNAs are
associated with regeneration For example, the inhibition
of miR-15 family members leads to increased mitosis of
cardiomyocytes in neonatal mice, promotes adult mouse
cardiomyocyte proliferation, improves cardiac function after MI
and improves contractile function after ischemia/reperfusion
injury (Hullinger et al., 2012; Porrello et al., 2012). miR-
133 is down-regulated during the period of cardiomyocyte
regeneration and proliferation in injured zebrafish myocardium,
implicating it in the regulation of cell cycle progression (Yin
et al., 2012). The inhibition of miR-34 family members has shown
therapeutic potential, where cardiac remodeling was attenuated
and improved cardiac function in mouse models of both pressure
overload and MI with up-regulation of growth factor target genes
including Vegf, Vcl, Sirt1, Notch1, and Pofut1 (Bernardo et al.,
2012; Boon et al., 2013). Lastly, inhibition of target genes of miR-
590 and miR-199a, such as Clic5, Hopx, and Homer1, using short
interfering RNAs, results in approximately double the number
of cardiomyocytes undergoing DNA synthesis and significantly
increased cytokinesis (Eulalio et al., 2012). Studying a model
organism for heart regeneration that closely reflects the cardiac
developmental timing of humans, such as sheep (Botting et al.,
2012; Lock et al., 2017, 2018; Morrison et al., 2018), may reveal
additional miRNAs that regulate cardiomyocyte proliferation,
and which may potentially have clinical relevance. We therefore
utilized a sheep model of MI to investigate the differential miRNA
expression in regenerative fetal hearts and non-regenerative
adolescent hearts.
MATERIALS AND METHODS
Animal Ethics and Housing
Experimental protocols for animal research were approved by
the South Australian Health and Medical Research Institute
(SAHMRI) Animal Ethics Committee (SAM046). Experiments
were designed and reported with reference to the ARRIVE
guidelines (Kilkenny et al., 2010). The experiments comply with
the policies and regulations of the European Convention for
the Protection of Vertebrate Animals used for Experimental and
other Scientific Purposes (Grundy, 2015). In total, 10 Merino
ewes and their fetuses and 12 adolescent sheep (∼6 months old)
were used in this study (supplied by South Australian Medical
Science Research Institute). Each ewe or adolescent sheep was
housed in an individual pen in an indoor housing facility
(Preclinical Imaging and Research Laboratories, SAHMRI) that
was maintained at a constant ambient temperature of between 20
and 22◦C with a 12 h light/dark cycle.
Surgical Procedure to Ligate the Left
Anterior Descending (LAD) Coronary
Artery
At 102 days gestation (term, 150 days), ewes underwent surgery
under aseptic conditions using general anaesthesia induced by
the intravenous infusion of diazepam (0.3 mg/kg) and ketamine
(7 mg/kg), and maintained with inhalation of isoflurane (1–
2%) in oxygen. Briefly, vascular catheters (Critchley Electrical
Products, Silverwater, Australia) were inserted as previously
described (Danielson et al., 2005; Duan et al., 2017; Lock et al.,
2020) in the maternal jugular vein, the amniotic cavity and the
fetal carotid artery and jugular vein.
Animals underwent thoracotomy and were randomly
allocated to Sham surgery (fetus, n = 5; adolescent sheep, n = 5)
or ligation of the left anterior descending (LAD) coronary artery
(fetus, n = 5; adolescent sheep, n = 5) to induce infarction.
Lignocaine was administered intravenously to all fetuses (0.2 mL
bolus) and adolescents (100 mg/500 mL) prior to incising the
pericardial sac. For animals in the infarction group, a silk suture
was placed around the second diagonal of the LAD coronary
artery and tied off, while observing blanching of the heart tissue.
The thoracotomy incision was tightly sutured in layers (ribs,
muscle and skin). The fetus was then returned to the ewe’s uterus
and the uterus was sutured closed.
Fetal catheters were exteriorized through a small incision
in the ewe’s flank. At surgery, antibiotics were administered
to the ewe (154 mg of Procaine penicillin, 393 mg of
benzathine penicillin, 500 mg of dihydrostreptomycin; Lyppards,
Adelaide, Australia) and fetuses (150 mg of Procaine penicillin,
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112 mg of benzathine penicillin, 250 mg of dihydrostreptomycin;
Lyppards). When the ewes and adolescent sheep recovered
from anesthesia, they were given analgesia (20 µg/kg, Xylazil,
Troy Laboratories, Australia). Antibiotics were administered
intramuscularly to each ewe or adolescent sheep for 3 days
after surgery and to each fetus intra-amniotically (500 mg of
ampicillin; Lyppards).
Post-mortem and Tissue Collection
On the 3rd day after ligation of the LAD coronary artery ewes and
adolescent sheep were humanely killed via overdose of sodium
pentobarbitone (8 g; Vibrac Australia, Peakhurst, Australia).
The ewes’ uterus was removed by hysterotomy, and the fetus
was removed and weighed. The heart was quickly dissected,
weighed and reverse perfused through the aorta with heparin
sulfate (5 mL; to prevent clotting and flush blood from the
heart) and a saturated KCl solution (5 mL; to arrest the heart
in diastole). The heart was photographed, cut into sections and
the infarct visualized using 2,3,5-triphenyltetrazolium chloride
(TTC) staining (as previously published; Duan et al., 2017; Lock
et al., 2019). A total of 10 fetuses [Sham, n = 5 (3 female, 2 male);
MI, n = 5 (3 male, 2 female)] and 10 adolescent sheep (Sham,
n = 5; MI, n = 5 all male) underwent post-mortem and were
used for molecular analyses. Ventricle tissue was collected from
the infarct area, the border zone (salvageable tissue immediately
surrounding the Infarct area) and a remote area of the left
ventricle, as well as the corresponding areas from Sham animals.
Tissue was either frozen in liquid nitrogen for miRNA microarray
and qRT-PCR analyses or fixed in 4% paraformaldehyde for
histological and immunohistochemistry analyses.
miRNA Microarray Analysis
A custom designed miRNA microarray was employed using a
service provider (LC Sciences, United States; Morrison et al.,
2015). It contained multiple (3–8) replicates of 3,098 probes
and multiple replicates (8–80) of 56 control probes. The
former probes were for identified ovine miRNA and additional
mammalian miRNA sequences downloaded from miRBase1,
as previously described (Morrison et al., 2015). The available
miRBase entries for ovine species are limited; however, since
many miRNAs are highly conserved amongst species, the
microarray was supplemented with miRNAs from other species.
The multispecies probes on the microarray caused redundancy
by design. The experimental design included three biological
replicates from each treatment group and age.
Background subtracted raw data from the manufacturer (LC
Sciences, United States; Casella and Berger, 2001; Bolstad, 2004)
was analyzed using a 2-factor ANOVA (factors: age (Fetus
and Adolescent) and region (Remote, Border and Infarct); 6
groups) (Eisen et al., 1998). Data was filtered at P < 0.05 for
each factor and the interaction. For miRNA probes identified
as significant for an interaction, one-way ANOVA was used
to determine significantly deregulated probes within each age
group. P-values for this analysis were not corrected for multiple
testing, as although there were 1894 expressed probes, many
1http://www.mirbase.org/
of these were for 808 unique miRNAs, with some probes
likely to also cross hybridize or reflect highly related miRNA
families. Thus, many of the probes on the microarray were not
independent. For each factor and interaction, the mean value of
all probes was taken for the six groupings (Fetal and Adolescent,
Remote, Border, and Infarct). Probes with overall mean signal
less than 500 (unreliable signal) as well as any probes with a
signal of zero in one or more sample (unreliable probes) were
then removed. K-means clustering was performed using the
CLCBIO Genomics Workbench program suite2 using the mean
probe values from each group. Data reported in the clustering
analysis are represented as untransformed raw signal. Euclidean
distance and K = 10 were selected for k-means clustering as
this revealed profile stability with the addition of further clusters
not creating any substantially different patterns. Unsupervised
principal component analysis (PCA) and hierarchical clustering
analyses of sample data used the default options in ClustVis3.
miRNA Target Prediction
Significantly deregulated probes were separated into groups
based on their expression profiles across tissue regions at both
ages. miRNA target predictions for the significantly up-regulated
or down-regulated probes in the Infarct samples compared to the
Remote samples was performed using miRWalk 3 (University of
Heidelberg4). miRNA target prediction involves high rates of false
positive targets and hence conservative strategies were utilized
(Pinzon et al., 2017). MiRWalk used a consensus approach
based on the intersection of at least three different methods
and utilized target mRNA information from the human, bovine,
and mouse genomes.
Predicted Target Term Enrichments
Gene Ontology (GO) term enrichments and KEGG pathway
functional enrichments were performed using miRWalk 3
by hypergeometric tests (Fisher-exact-test). Redundant terms
generated by the multiple species background were removed.
Only enriched terms with an FDR corrected P < 0.05 were used.
Real-Time PCR for miRNA and Target
Genes
All essential information regarding the qRT-PCR procedure
is included as per the MIQE guidelines (Bustin et al., 2009).
Total RNA was extracted from frozen heart tissue for each fetus
and adolescent sheep using QIAzol Lysis Reagent solution and
QIAgen miRNeasy purification columns, as per manufacturer
guidelines (Qiagen, Germany). Total RNA was quantified by
spectrophotometric measurements at 260 and 280 nm in a
NanoDrop Lite Spectrophotometer (Thermo Fisher Scientific)
and the 260/280 nm ratio. RNA samples were checked for
integrity, as well as protein and DNA contamination using
spectrophotometer results and agarose gel stained using
ethidium bromide. cDNA was synthesized using Superscript
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using 1 µg of total RNA, random hexamers, dNTP, DTT
and Superscript III in a final volume of 20 µL, as per the
manufacturer’s guidelines in a MJ Mini personal thermocycler
(Biorad, United States). Controls containing either no RNA
transcript or no Superscript III were used to test for reagent
contamination and genomic DNA contamination, respectively.
miRNA cDNA was synthesized using the miScript II RT Kit
(Qiagen, Germany) according to the manufacturer’s guidelines.
Each sample contained 4 µL 5x miScript Hiflex buffer, 2 µL
10x Nucleics mix, 2 µL miScript Reverse Transcriptase
mix and 1 µg extracted RNA. The no amplification control
(NAC) negative control samples replaced the miScript Reverse
Transcriptase mix with 2 µL of molecular grade water. The
geNorm component of qbaseplus 2.0 software (Biogazelle,
Belgium) was used to determine the most stable reference
genes from a panel of candidate reference genes (Vandesompele
et al., 2002) and the minimum number of reference genes
required to calculate a stable normalization factor, as previously
described (Soo et al., 2012; McGillick et al., 2013). For qRT-
PCR data output normalization, three stable reference genes
RPLP0 (NM_001012682.1), HPRT1 (NM_001034035.1) and
YWHAZ (AY970970) (Passmore et al., 2009) were run in parallel
with all target genes, as previously described. For miRNA
qRT-PCR, target miRNAs were normalized against miR-208
(MI0000251); miR-92-1 (MS00006594) and SNORD61-1
(MS00033705, QIAGEN, Australia). Relative expression of target
genes (BIRC5, NM_001001855.2; SPAG5, XM_004012500.1;
CHEK1, XM_004019518.1; CDK1, NM_001142509.1;
GJA1, XM_004011159.1; CTGF, NM_001164714.1;
PGAM1, NM_001034054; SRF, XM_004019222.1; CLIC5,
XM_004018860.1; HOPX, NM_174097.2, and HOMER1,
NM_001076052.1) and miRNAs (miR-15a, MS00008785; miR-
15b, MS00008799; miR-16, MS00031493; miR-195, MS00008953;
miR497, MS00031906; miR-199a, MS00007602; and miR-590,
MS00010269; QIAGEN, Australia) were measured by qRT-PCR
using KiCqStart SYBR Green qPCR ReadyMix (Sigma Aldrich,
United States) or miScript SYBR Green PCR Kit (QIAGEN,
Australia) in a final volume of 6 µL on a ViiA7 Fast Real-time
PCR system (Applied Biosystems, United States) as previously
described. Each qRT-PCR well contained 3 µL SYBR Green
Master Mix (2X), 2 µL of forward and reverse primer mixed with
H2O to obtain final primer concentrations and 1 µL of diluted
relevant cDNA. Each sample was run in triplicate for target
genes and reference genes. The abundance of each transcript
relative to the abundance of stable reference genes (Hellemans
et al., 2007) was calculated using DataAssist 3.0 analysis software
(Applied Biosystems, United States) and expressed as mRNA
mean normalized expression (MNE) ± SEM. Outliers were
identified using the ROUT method with a false discovery rate
Q = 1% (GraphPad Prism 8, United States) and were removed
from the analysis.
H9c2 Cell Culture Experiments
H9c2 cells derived from rat embryonic ventricular
cardiomyoblasts were cultured in Glutamax DMEM (Gibco,
United States) media that contained 10% (v/v) fetal bovine serum
and 1% v/v penicillin/streptomycin at 37◦C in an atmosphere
of 95% air and 5% CO2. Hypoxia was induced by incubation
in sealed hypoxia chambers containing 94% N2, 5% CO2, and
1% O2 to simulate tissue hypoxia during ischemia (Yao et al.,
2017). Since miRNAs are generally conserved between species,
we first checked that the sequences of the chosen miRNAs were
not different between species using miRbase (University of
Manchester1) and used the HSA version of the miRNA for the
remainder of the experiments to improve interspecies translation.
Cells were seeded into 6-well-plates at a density of 100,000 cells
per well and 96-well-plates at 5000 cells per well. 100 nmol
miRNA-inhibitors [hsa-miR-558, hsa-miR-1538, hsa-miR-150
or the manufacturer negative control 5 (NC5) miRNA (IDT,
United States)] were each diluted in 125 µL OPTIMEM media
(Gibco, United States) and combined with Lipofectamine 2000
(Thermo Fisher Scientific, United States) before further dilution
in culture media. Cells were treated with either normal media
Glucose/Normoxia, No-Glucose/Normoxia, Glucose/Hypoxia
or No-Glucose/Hypoxia culture conditions for 48 h to simulate
lack of oxygen and glucose supply during an infarction.
Cells in 6-well-plates were either lysed in Qiazol (Qiagen,
United States) for qRT-PCR or fixed in 4% formaldehyde (Sigma
Aldrich, United States) for subsequent immunohistochemistry
analysis. 96-well-plates were aspirated of culture media after
treatment and 100 µL fresh media was added to each well.
Twenty microliter of MTS Proliferation assay reagent (Promega,
United States) was then added to each well and incubated for 2 h
at 37◦C. Thereafter the absorption of each well was measured
at the wavelength of 490 nm by a spectrophotometer. Potential
target genes of novel miRNAs were determined using miRWalk
3 (University of Heidelberg4). Target genes were selected based
on how significantly likely they were to be modulated by the
miRNAs of interest and are expressed in cardiac tissue. The
expression of target genes PAPPA, JAG, NF2, MYOC1, and SOX4
act as markers to ensure that miRNA inhibition is effectively
associated an upregulation of target gene expression.
Immunohistochemistry
Rehydrated cardiomyoblasts were blocked for endogenous
peroxidase activity with 3% hydrogen peroxide (Sigma-Aldrich,
United States), followed by heat-induced antigen retrieval
in sodium-citrate buffer (pH 6.0). Slides were incubated
overnight with the primary antibody (Aurora-B, ab2254, Abcam,
United States) at 4◦C following incubation with non-immune
serum (serum-blocking solution; Histostain-Plus Kit; Invitrogen,
United States) to prevent non-specific binding. Negative control
slides with the primary antibody omitted were used to
demonstrate the absence of non-specific binding of the secondary
antibody or reagent contamination. In addition, negative control
slides, where primary antibody was substituted by rabbit serum
(Sigma-Aldrich, United States) were carried out at the same
protein concentration as the diluted primary antibodies (Hewitt
et al., 2014). Negative controls were incubated overnight at 4◦C in
parallel with test slides under the same experimental conditions.
A Histostain-Plus kit (Invitrogen, United States) was used with
horseradish peroxidase and Histostain-Plus broad spectrum 3,3’-
diaminobenzidine (DAB) chromagen for visualization of positive
cells. All sections were counterstained with Mayer’s hematoxylin
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(Sigma-Aldrich, United States). Following optimization, the
substrate-chromagen reaction was allowed to occur for the same
time for all slides. Images of stained slides were taken using
a NanoZoomer-XR (Hamamatsu, Japan) and quantified using
the VIS software package (Visiopharm, Denmark), as previously
described (Lock et al., 2015).
Statistical Analysis
Statistical analyses for qRT-PCR and immunohistochemistry
were performed within the STATA 12 program (StataCorp,
United States). Analyses between tissue regions (Infarct vs.
Border vs. Remote) at each age were assessed using a nested
Analysis of Variance (ANOVA). A Bonferroni post hoc test was
performed with multiple comparisons for each tissue region
against the Sham tissue.
RESULTS
Two strategies were employed to assess the expression of
miRNAs after MI in the fetus and adolescent sheep heart
samples. qRT-PCR was used to evaluate changes in the
expression of key miRNAs and their target genes, which
have been identified as playing important roles in cardiac
regeneration in zebrafish and mouse models. miRNA microarray
analysis provided a more comprehensive analysis to profile
3,098 probes representing miRNAs from several mammalian
species, to then identify differentially expressed probes, and to
predict mRNA targets and enriched functions associated with
clustered unique miRNAs.
Profiling of Zebrafish and Mouse
miRNAs Implicated in Cardiac
Regeneration in Sheep
A number of miRNAs have been identified as possible therapeutic
targets in small animals, which retain heart regenerative capacity
for a period of time after birth. The most promising of
these candidate miRNAs were investigated in our large animal
model to determine if the changes in miRNA expression are
consistent across species.
miR-15 Family
The miR-15 family contains five miRNA, miR-15a, miR-
15b, miR-16, miR-195, and miR-497. In the ventricular tissue
from adolescent animals there was a significant increase in
expression of miR-15a in the Infarct sample compared to the
Remote samples and Sham controls (Figure 1A; P = 0.017,
0.0017, respectively). miR-15b was decreased in the Border and
Infarct samples compared to both the Remote samples and
Sham controls in the fetuses (Figure 1B; P ≤ 0.05, < 0.001,
respectively). In the adolescent sheep, there was an increase in
miR-15b expression in the Infarct samples compared to Sham
controls, as well as Remote and Border samples (Figure 1B;
P = 0.007, P < 0.001, respectively). The expression of miR-16
was decreased in the fetal Border and Infarct samples compared
with the Remote sample (P < 0.05) and was increased in
the Infarct sample compared with Remote samples (P < 0.05)
in the adolescent sheep (Figure 1C). miR-195 expression was
increased in the fetal Border and Infarct samples compared to
Remote samples (Figure 1D; P < 0.05). In the adolescent animals
there was an increase in expression of miR-195 in the Infarct
samples compared to Remote and Sham samples (Figure 1D;
P < 0.05, P < 0.001 respectively). The expression of miR-497
was significantly decreased in the fetal Infarct samples compared
to Border samples (Figure 1E; P < 0.05). In the adolescent
sheep there was an increase in miR-497 expression in the Infarct
samples compared to Remote and Sham samples (Figure 1E,
P < 0.05, P = 0.007 respectively). miR-15 family target genes
demonstrated similar expression profiles (Figure 2).
miR-133a
The expression of miR-133a was significantly down-regulated in
fetal Infarct compared to Border samples (Figure 3A; P < 0.05).
In adolescent sheep, there was a significant decrease in Infarct
compared to Remote, Border and Sham samples (Figure 3A;
P < 0.001, P < 0.05, P < 0.001, respectively). The higher
expression of this miRNA in adolescent sheep is consistent
with increased expression of miR-133a with age in multiple
species (Liu et al., 2008; Morrison et al., 2015); but, the
decreased expression in the Infarct samples within adolescent
sheep was unexpected. miR-133a target gene expression did not
mirror the expression of miR-133a (Figures 3B–E).
miR-34 Family
miR-34a expression was significantly higher in the adolescent
sheep heart samples compared to the fetuses (P < 0.0001,
Supplementary Files). There was no significant difference in the
expression of miR-34a in the fetal Infarct samples after MI; but,
miR-34awas down-regulated in the adolescent Infarct samples
compared to Remote samples (P = 0.018, Supplementary Files).
miR-34b expression was not significantly different at either age.
miR-25
miR-25 is another miRNA that has a reported role in
cardio-protection after infarction. Interestingly, in the current
investigation miR-25 was not significantly changed in the fetal
heart in response to MI, but this miRNA was up-regulated in the
Infarct samples in the adolescent animals compared to Remote
samples (P < 0.004, Supplementary Files).
miR-199a
miR-199a and miR-590 have cardioprotective roles after
infarction in mice (Eulalio et al., 2012; Ali, 2013; Wang and
Martin, 2014). miR-199a was significantly up-regulated in
the Infarct samples compared to the Remote samples in both
fetuses and adolescent sheep (P = 0.009, P = 0.007, respectively,
Supplementary Files). However, their target genes were up-
regulated in the infarct area compared to Remote and Sham
samples, indicating that these miRNAs have a smaller role in
sheep cardiac regeneration (Supplementary Figure 1).
miR-17∼miR-92 Cluster
The miR-17∼miR-92 cluster of miRNAs are also potential
promoters of cell cycle in mice and sheep that are down-regulated
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FIGURE 1 | Expression of the miR-15 family in sheep 3 days post-MI. Mean normalized expression (MNE) of miR-15a (A), miR-15b (B), miR-16 (C), miR-195 (D),
and miR-497 (E) in Sham, Remote, Border zone, and Infarct Tissue. Superscript letters (Fetal Sheep; a, b and Adolescent Sheep; x, y) represent significance
between tissue regions (Remote, Border and Infarct) at each age (P < 0.05). *Represents significantly different data from the sham animals at each age (P < 0.05).
Analyses between tissue regions (Infarct vs. Border vs. Remote) at each age were assessed using a nested Analysis of variance (ANOVA). A Bonferroni post hoc test
was performed with multiple comparisons for each tissue region against the Sham tissue. n = 5 per treatment group per age.
at birth (Chen et al., 2013; Morrison et al., 2015). miR-17, miR-
18a and miR-92a expression were significantly higher in the
fetuses compared to adolescent sheep (P = 0.01, 0.004, 0.02,
respectively, Supplementary Files); however, there was no effect
of MI on expression at either age. Expression of miR-19a was
too low for statistical analysis, but miR-19b was highly expressed
in fetuses, although expression remained unchanged between
the MI tissue regions. However, miR-19b was significantly up-
regulated in the adolescent sheep in the Infarct samples compared
to Remote samples (P = 0.03, Supplementary Files). Expression
of miR-20a and miR-20b expression were higher in the fetuses
compared to the adolescent animals (P = 0.03, P = 0.007,
respectively, Supplementary Files), but were unchanged at both
ages in response to MI.
miRNA Microarray Analysis
miRNA Probe PCA Analysis and Clustering
miRNA microarrays were used to investigate the immediate
miRNA response to infarction [n = 3 per tissue region (Infarct,
Border, Remote) and at each age (Fetal, Adolescent)]. This
approach complements the qRT-PCR targeted miRNA approach
and has the potential to identify additional miRNAs and broad
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FIGURE 2 | qRT-PCR validation of miR-15 family target mRNA expression in sheep 3 days post-MI. Mean normalized expression (MNE) of BIRC5 (A), SPAG5 (B),
CHEK1 (C), and CDK1 (D) in Sham, Remote, Border zone, and Infarct Tissue. Superscript letters (Fetal Sheep; a, b and Adolescent Sheep; x, y) represent
significance between tissue regions (Remote, Border and Infarct) at each age (P < 0.05). *Represents significantly different data from the sham animals at each age
(P < 0.05). Analyses between tissue regions (Infarct vs. Border vs. Remote) at each age were assessed using a nested Analysis of Variance (ANOVA). A Bonferroni
post hoc test was performed with multiple comparisons for each tissue region against the Sham tissue. n = 5 per treatment group per age.
functional themes associated with cardiac regeneration in sheep.
A PCA analysis of the microarray data shows separation of
the two age groups and three treatment groups as well as
clustering of the biological replicates within each of the groups
(Figure 4). The PC2 dimension separated the groups on the basis
of age, while separation of groups along PC1 highlighted the
infarction response for both ages. The fetal Remote and Border
samples were nearly superimposable. Overall, the fetal response
to infarction was more constrained than the adolescent response.
The adolescent Border sample showed considerable variance
along PC1. The analysis demonstrates that multiple miRNAs have
altered expression in the response to cardiac damage in the sheep;
this suggests substantial complexity in the miRNA regulation of
the heart regenerative response.
K-means clustering (k = 10) of the significant differentially
expressed (DE) probes was undertaken separately at each age.
This analysis clusters together miRNAs with similar expression
changes in response to MI (Table 1 and Supplementary
Figures 2, 3). Clusters 7, 8, and 9 in the adolescent animals
were combined for mRNA target prediction as they contained
multispecies probes for the same miRNAs. Cluster 1 in the
fetal samples had insufficient mRNA targets for gene ontology
analysis. Clusters 3 and 6 in the fetuses and Cluster 5 in adolescent
sheep were the largest, containing 41, 46, and 58 probes
respectively. Cluster 3 in the fetal samples showed an overall
increase in expression in Infarct compared to Remote samples,
while Cluster 6 showed an overall decline in miRNA expression in
the Infarct samples compared to the Remote samples. In the fetal
samples, Clusters 1, 2, 3, 4, and 5 were all increasing expression
in the Infarct samples compared with Remote samples. Clusters
6, 7, 9, and 10 all had declining expression in the Infarct samples
compared with Remote samples. In the adolescent sheep Clusters
1, 3, 4, 6, 7, 9, and 10 all had increased expression in the Infarct
samples compared with Remote samples. Clusters 2, 5, and 8
were all declining expression in the Infarct samples compared
with Remote samples.
miRNA qRT-PCR Expression Validation
By design, a single miRNA could be separated into multiple
clusters due to the array featuring multiple species probes for
the same miRNA or probes identifying miRNA family variants.
The miRNA expression patterns measured using qRT-PCR were
generally consistent with the expression measured by the miRNA
microarray. Probes for miR-15a and miR-16 were present in
Clusters 3 and 5 in the fetuses and Clusters 1 and 6 in the
adolescent sheep. These clusters had increased expression in
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FIGURE 3 | qRT-PCR validation of miR-133a and mRNA target expression in sheep 3 days post-MI. Mean normalized expression (MNE) of miR-133a (A), GJA1 (B),
CTGF (C), PGAM1 (D), and SRF (E) in Sham, Remote, Border zone, and Infarct Tissue. Superscript letters (Fetal Sheep; a, b and Adolescent Sheep; x, y) represent
significance between tissue regions (Remote, Border, and Infarct) at each age (P < 0.05). *Represents significantly different data from the sham animals at each age
(P < 0.05). Analyses between tissue regions (Infarct vs. Border vs. Remote) at each age were assessed using a nested Analysis of variance (ANOVA). A Bonferroni
post hoc test was performed with multiple comparisons for each tissue region against the Sham tissue. n = 5 per treatment group per age.
the Infarct samples compared to Remote samples, which was
consistent with qRT-PCR miR-15a expression, whereas miR-16
was down-regulated in fetal Infarct samples in the qRT-PCR data
but increased in the microarray data. This latter difference may
be explained because the clustered probes for miR-16 were for
the miR-16a and miR-16c-5p variants, which were not specifically
measured in qRT-PCR. Probes for miR-133a were present in
Clusters 6 and 7 in the fetus and Clusters 2, 5, and 8 in the
adolescent sheep. These clusters all had decreasing expression
profiles that mirrors the qRT-PCR data for miR-133a where
there was decreased expression in the Infarct compared with
Border samples in the fetal samples and decreased expression in
the Infarct compared with the Border and Remote samples in
the adolescent sheep. Fold change comparisons (Infarct/Remote)
of miRNAs using both methods at each age showed strong
correlations with r2 = 0.91, 0.84, 0.93 and 0.90 (P < 0.0001,
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FIGURE 4 | Principal component analysis (PCA) of miRNA expression using all samples. The ellipses show the 95% confidence level for each group. Each group
consisted of samples from three animals. The variance explained in each principal component (PC) is shown in brackets. The PC2 dimension separated the groups
on the basis of age while separation of groups along PC1 highlighted the infarction response for both ages. The fetal Remote and Border samples were near
superimposable. The adolescent Border sample showed considerable variance along PC1.
P < 0.0001) for fetus and adolescent samples, respectively
(Supplementary Figure 4).
miRNA Target Prediction and Pathway
Enrichment
Microarray probes that were significantly differentially regulated
in the Infarct compared to Remote samples were grouped
based on expression profile (higher or lower in the Infarct
compared to Remote samples at each age group). Since
miRNAs have a large number of target mRNAs, and these
targets often overlap, there was a high level of consistency
between pathways of predicted targets of miRNAs between
fetal and adolescent sheep (Supplementary File 2). The
most enriched KEGG pathway terms at both ages for the
mRNA targets predicted from the significantly deregulated
miRNAs included: Pathways in cancer (map05200), MAPK
signaling pathway (map04010), Axon guidance (map04360),
Proteoglycans in cancer (map05205), cAMP signaling pathway
(map04024), Ras signaling pathway (map04014), Signaling
pathways regulating pluripotency of stem cells (map04550),
Wnt signaling pathway (map04310), Leukocyte transendothelial
migration (map04670), Endocytosis (map04144) (Supplementary
File 2). The most enriched gene ontology terms using Biological
Process for the significantly deregulated miRNAs at both ages
included: Canonical Wnt signaling pathway (GO:0060070), Wnt
signaling pathway (GO:0016055), Angiogenesis (GO:0001525),
Protein ubiquitination (GO:0016567), Positive regulation of
GTPase activity (GO:0043547), Nervous system development
(GO:0007399), Regulation of transcription from RNA polymerase
II promoter (GO:0006357), Covalent chromatin modification
(GO:0016569).
Due to the high level of similarity in pathways of
predicted target mRNAs at both ages, target genes were
also predicted for the uniquely up-regulated and uniquely
down-regulated miRNAs at each age. To do this, miRNAs
with the same direction of change between fetuses and
adolescent sheep were removed and gene target prediction
was repeated. This method was used to identify pathways
that were differentially regulated as a function of age in
response to infarction (Tables 2, 3). Predicted mRNAs of the
uniquely deregulated miRNAs that were oppositely expressed
in fetuses and adolescent sheep were significantly enriched for
FoxO signaling pathway (map04068), Proteoglycans in cancer
(map05205) and Neurotrophin signaling pathway (map04722)
KEGG terms (Table 2). Insulin signaling pathway (map04910)
and Sphingolipid signaling pathway (map04071) were uniquely
enriched for the predicted target genes of up-regulated
and down-regulated miRNAs, respectively, in the fetuses
(Table 2). Rap1 signaling pathway (map04015) and Fc gamma
R (map04666) were both uniquely enriched for the predicted
target genes of up-regulated miRNAs whereas Wnt signaling
pathway (map04310) was enriched for the predicted target
genes of down-regulated miRNAs in the adolescent Infarct
samples (Table 2). Uniquely enriched gene ontology terms
for Biological Processes included Canonical Wnt signaling
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TABLE 1 | miRNA expression k-means clusters.
Fetal cluster number Direction of change miRNA
1 Increased in infarct miR-21, miR-21a-5p, miR-451, miR-7641
2 Increased in infarct let-7j, miR-1273e, miR-1285, miR-155, miR-199a-3p, miR-21, miR-222a-3p, miR-223-3p, miR-2478,
miR-25, miR-25-3p, miR-29a, miR-376c-3p, miR-381, miR-381-5p, miR-3957-3p, miR-451, miR-451b,
miR-5100, miR-6236, miR-6240, miR-7977
3 Increased in infarct miR-106a, miR-1224-5p, miR-1246, miR-125b, miR-125b-5p, miR-1260, miR-1260a, miR-1260b,
miR-1285, miR-1357, miR-1386, miR-142-3p, miR-15a, miR-16a, miR-1895, miR-199b, miR-19b,
miR-20a, miR-20b, miR-21, miR-223, miR-2311, miR-2478, miR-2887, miR-2888, miR-29a-3p,
miR-29d-3p, miR-30b-3p, miR-339b, miR-379-5p, miR-3968, miR-4454, miR-4792, miR-486-5p,
miR-5100, miR-6119-5p, miR-6240, miR-6412, miR-716a, miR-716b, miR-7641
4 Increased in infarct let-7i, miR-1246, miR-1254, miR-127, miR-1273e, miR-1285, miR-140, miR-16c-5p, miR-199a-3p,
miR-199a-5p, miR-199c, miR-21, miR-2137, miR-214, miR-221, miR-222, miR-30c, miR-451, miR-5126,
miR-6323, miR-6236-p5
5 Increased in infarct miR-451, miR-7641, miR-21
6 Decreased in infarct let-7e-5p, miR-1, miR-100, miR-1285, miR-133a-5p, miR-1386, miR-139, miR-1-3p, miR-150,
miR-151-5p, miR-151b, miR-181a, miR-1973, miR-224, miR-23b, miR-23b-3p, miR-24, miR-28c,
miR-29a, miR-30a-3p, miR-30c, miR-30d, miR-30d-5p, miR-30e-3p, miR-30f, miR-331-3p, miR-339b,
miR-3431, miR-374b, miR-378, miR-378a, miR-378b, miR-378c, miR-378d, miR-378e, miR-378f,
miR-378g, miR-378i, miR-4454, miR-452-3p, miR-558, miR-574, miR-6240, miR-669e, miR-7641,
miR-99a
7 Decreased in infarct miR-1, miR-133, miR-133a, miR-133a-3p, miR-133b, miR-133b-3p, miR-374a, miR-499, miR-499-5p,
miR-499b-5p
9 Decreased in infarct miR-133c, miR-145, miR-30a-5p, miR-30b, miR-30b-5p, miR-30c, miR-30c-5p, miR-30d, miR-30e-5p,
miR-30f, miR-499
10 Decreased in infarct miR-125a, miR-125a-5p, miR-1386, miR-1538-p3, miR-181a-5p, miR-181c, miR-2487-p5, miR-30d,
miR-4448, miR-4454, miR-5100, miR-6240-p3, miR-716a-p5, miR-716b
Adolescent cluster number Direction of change
1 Increased in infarct let-7j, miR-1260b, miR-1285, mir-1538, miR-16c-5p, miR-21, miR-223, miR-30c-1-3p, miR-3957-3p,
miR-4454, miR-5100, miR-5126, mir-6236, mir-6240, mir-716a, miR-716b, miR-7977
2 Decreased in infarct miR-34a, miR-125b, miR-125b-5p, miR-133a, miR-133b-3p, miR-133c, miR-185, miR-197, miR-22-3p,
miR-22-5p, miR-23b, miR-24, miR-27b, miR-30a-5p, miR-30b, miR-30b-5p, miR-30c, miR-30c-5p,
miR-30d, miR-30d-5p, miR-30e-5p, miR-30f, miR-99a.
3 Increased in infarct let-7i, miR-106a, miR-106b, miR-1224-5p, miR-1260b, miR-127, miR-1386, miR-150, miR-155, miR-15a,
miR-1895, miR-199a-3p, miR-199b, miR-19b, miR-20a, miR-20b, miR-2478, miR-25, miR-25-3p,
miR-2887, miR-2888, miR-29a, miR-30b-3p, miR-339b, miR-376c-3p, miR-376e-3p, miR-379-5p,
miR-3968, miR-409-3p, miR-4454, miR-4792, miR-487b-3p, miR-5100, miR-558, miR-6119-5p,
miR-7641
4 Increased in infarct miR-106a, miR-1246, miR-1260, miR-1260a, miR-1260b, miR-1285, miR-1357, miR-142-3p,
miR-15a-5p, miR-199a-3p, miR-199a-5p, miR-199c, miR-2137, miR-214, miR-2313-5p, miR-2311,
miR-2478, miR-2487, miR-381-5p, miR-4454, miR-4484, miR-451b, miR-5100, miR-6236-5p, miR-6240,
miR-6323, miR-6412, miR-716a, miR-716b, miR-7641
5 Decreased in infarct miR-1, miR-100, miR-103-3p, miR-125a, miR-125a-5p, miR-133a-5p, miR-139, miR-1-3p, miR-148b,
miR-151-5p, miR-151b, miR-181a, miR-181a-5p, miR-181c, miR-1973, miR-23a-3p, miR-221, miR-222,
miR-222a-3p, miR-224, miR-23b-3p, miR-23b, miR-26-5p, miR-28c, miR-29a, miR-29a-3p, miR-29b,
miR-29d-3p, miR-2284x, miR-30a-3p, miR-30a-5p, miR-30b, miR-30c, miR-30c-5p, miR-30d-5p,
miR-30e-3p, miR-30f, miR-331-3p, miR-339b, miR-3431, miR-361, miR-374b, miR-378, miR-378a,
miR-378b, miR-378c, miR-378d, miR-378e, miR-378f, miR-378i, miR-424-5p, miR-452-3p, miR-486,
miR-486-5p, miR-4306, miR-574, miR-669e, miR-99a
6 Increased in infarct miR-1246, miR-1254, miR-1273e, miR-1285, miR-16a, miR-21, miR-223-3p, miR-451
7 Increased in infarct miR-7641
8 Decreased in infarct miR-1, miR-133, miR-133a, miR-133a-3p, miR-133a-p5, miR-133b, miR-499, miR-499-5p,
miR-499b-5p, miR-193b
9 Increased in infarct miR-1273e, miR-21, miR-451, miR-7641
10 Increased in infarct miR-21, miR-21a-5p, miR-7641
Differentially expressed microarray probes were first identified and subjected to k-means clustering. All species identifiers were then removed and a non-redundant list of
miRNAs was obtained. Anonymous probes beginning with the designation “PC” were excluded. A full list of probes with species identifiers can be found in Supplementary
File 1. miRNAs that were included in the targeted analysis of previously implicated miRNAs in mouse and zebrafish studies using qRT-PCR analyses are highlighted in
bold.
pathway (GO:0060070) and Endocytosis (GO:0006897), which
were oppositely regulated at each age (Table 3). Wnt signaling
pathway (GO:0016055) was uniquely enriched for the predicted
target genes of up-regulated miRNAs in the fetuses (Table 3).
Whereas Collagen fibril organization (GO:0030199), Intracellular
protein transport (GO:0006886), and Protein localization to
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TABLE 2 | Top 10 KEGG pathway enrichment terms for predicted targets of uniquely deregulated miRNAs in the infarct compared to remote samples.
Treatment group KEGG pathway terms Term accession Pathway hits Padj
Predicted targets of fetal up-regulated miRNAs Axon guidance map04360 98 0.000
Pathways in cancer map05200 180 0.000
FoxO signaling pathway map04068 73 0.0091
Proteoglycans in cancer map05205 101 0.0091
MAPK signaling pathway map04010 119 0.0091
Insulin signaling pathway map04910 75 0.0091
ErbB signaling pathway map04012 51 0.0102
Ras signaling pathway map04014 109 0.0102
AMPK signaling pathway map04152 68 0.0109
Regulation of actin cytoskeleton map04810 103 0.0109
Predicted targets of fetal down-regulated miRNAs Axon guidance map04360 119 0.000
Ras signaling pathway map04014 142 0.000
Pathways in cancer map05200 229 0.000
AMPK signaling pathway map04152 87 0.007
Oxytocin signaling pathway map04921 101 0.0081
ErbB signaling pathway map04012 64 0.0081
Neurotrophin signaling pathway map04722 82 0.0081
cAMP signaling pathway map04024 119 0.0106
MAPK signaling pathway map04010 145 0.0113
Sphingolipid signaling pathway map04071 82 0.0113
Predicted targets of adolescent up-regulated miRNAs Endocytosis map04144 123 0.000
Axon guidance map04360 81 0.0055
Ras signaling pathway map04014 98 0.0055
Regulation of actin cytoskeleton map04810 95 0.0055
Neurotrophin signaling pathway map04722 62 0.0055
AMPK signaling pathway map04152 62 0.0069
Rap1 signaling pathway map04015 91 0.0069
Fc gamma R map04666 47 0.0069
Pathways in cancer map05200 150 0.0082
cAMP signaling pathway map04024 85 0.0082
Predicted targets of adolescent down-regulated miRNAs MAPK signaling pathway map04010 169 0.000
Axon guidance map04360 127 0.000
Wnt signaling pathway map04310 106 0.000
Pathways in cancer map05200 258 0.000
Proteoglycans in cancer map05205 136 0.0041
FoxO signaling pathway map04068 98 0.0041
Ras signaling pathway map04014 152 0.0041
cAMP signaling pathway map04024 130 0.0072
Oxytocin signaling pathway map04921 107 0.0078
ErbB signaling pathway map04012 67 0.0078
P-values were corrected for multiple testing using Benjamini-Hochberg method. Padj is the FDR q-value. All enrichments were performed through miRWalk.
plasma membrane (GO:0072659) were uniquely enriched in the
adolescent sheep.
Identification of Potential miRNA Targets
for Treatment of Cardiac Disease
miRNA responses to infarction at one age, but not the other may
potentially contribute to the differing physiological responses
to infarction at the fetal and adolescent ages, and therefore
are of particular interest. These specific miRNA responses may
underpin the differing repair capacities of fetal and adolescent
sheep heart tissues. Several miRNAs were detected that had
opposite expression profiles in fetus compared with adolescent
sheep (Figure 5). miR-140 was uniquely up-regulated in fetal
Infarct compared to Remote samples. This miRNA has a role
in cardiac muscle hypertrophy (Joshi et al., 2016) as well
as mitochondrial fission and apoptosis through mitofusin 1
(Mfn1) in rat hearts (Li et al., 2014). Five miRNAs were
significantly down-regulated in the fetal Infarct compared to
the Remote samples (let-7e, miR-145, miR-374a, miR-378g, and
miR-4448; Figure 5). Some of these miRNAs were previously
investigated including miR-145, which protects the heart from
autophagy after infarction in rabbits (Higashi et al., 2015),
but hypoxia downregulates the expression of this miRNA in
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TABLE 3 | Top 10 gene ontology biological process terms for predicted mRNA targets of uniquely deregulated miRNAs.
Treatment group Biological processes Term accession Pathway hits Padj
Predicted targets of fetal up-regulated miRNAs Protein ubiquitination GO:0016567 153 0.0001
Response to ATP GO:0033198 38 0.0003
Peptidyl-serine phosphorylation GO:0018105 114 0.0007
Adenosine catabolic process GO:0006154 23 0.0007
Intracellular signal transduction GO:0035556 213 0.0007
Protein dephosphorylation GO:0006470 98 0.0011
Cellular response to heat GO:0034605 39 0.0013
Positive regulation of NF-kappaB transcription factor activity GO:0051092 88 0.0014
Canonical Wnt signaling pathway GO:0060070 111 0.0015
Wnt signaling pathway GO:0016055 127 0.0017
Predicted targets of fetal down-regulated miRNAs Water transport GO:0006833 44 0.0008
Positive regulation of MAPK cascade GO:0043410 83 0.0011
Peptidyl-serine phosphorylation GO:0018105 139 0.0014
Intracellular signal transduction GO:0035556 262 0.0016
Endocytosis GO:0006897 131 0.0035
Protein ubiquitination GO:0016567 174 0.0037
Peptidyl-tyrosine dephosphorylation GO:0035335 44 0.0039
Response to ATP GO:0033198 40 0.0041
Protein polyubiquitination GO:0000209 89 0.0045
Actin cytoskeleton organization GO:0030036 104 0.0052
Predicted targets of adolescent up-regulated miRNAs Nervous system development GO:0007399 192 0.0001
Intracellular signal transduction GO:0035556 193 0.0002
Sensory perception of sound GO:0007605 107 0.0006
Neuron migration GO:0001764 90 0.0008
Collagen fibril organization GO:0030199 44 0.001
Endocytosis GO:0006897 97 0.0011
Intracellular protein transport GO:0006886 107 0.0012
Positive regulation of I-kappaB kinase/NF-kappaB signaling GO:0043123 83 0.0015
Memory GO:0007613 54 0.0016
Peptidyl-serine phosphorylation GO:0018105 98 0.0018
Predicted targets of adolescent down-regulated miRNAs Neuron migration GO:0001764 141 0.0001
Peptidyl-serine phosphorylation GO:0018105 153 0.0004
Intracellular signal transduction GO:0035556 288 0.0004
Protein autophosphorylation GO:0046777 175 0.0011
Protein localization to plasma membrane GO:0072659 117 0.0012
Canonical Wnt signaling pathway GO:0060070 147 0.0015
Nervous system development GO:0007399 134 0.0015
cAMP catabolic process GO:0006198 21 0.0015
Protein ubiquitination GO:0016567 189 0.0019
Actin cytoskeleton organization GO:0030036 59 0.0025
P-values were corrected for multiple testing using Benjamini-Hochberg method. Padj is the FDR q-value. All enrichments were performed through miRWalk.
mouse cardiac fibroblasts (Wang et al., 2014). miR-374 regulates
vascular endothelial growth factor receptor-1 signaling in rats
and modulates the inflammatory process in humans (Lee et al.,
2017; Doumatey et al., 2018). 14 miRNAs were uniquely down-
regulated in the adolescent Infarct compared to Remote samples
(Figure 5) and included some miRNAs known to be involved
in rodent cardiac regeneration, including miR-34a (a miRNA
associated with cardiac repair in mice; Yang et al., 2015) and
miR-26, which plays a major role in regulating cardiac collagen
I expression in rats (Zheng et al., 2018). Inhibition of the miR-34
family has been shown to have therapeutic potential for human
cardiac pressure overload and MI (Bernardo et al., 2012; Boon
et al., 2013; Lock et al., 2017). The expression of the miR-34
family is increased in the mouse heart after MI (Lin et al., 2010)
and in cardiac tissue from patients with heart disease (Thum
et al., 2007; Greco et al., 2012). In sheep heart tissue we observed
the opposite expression profile, with down-regulation of miR-
34a in Infarct compared to Remote samples in adolescent sheep
and no change in fetal expression. This result indicates that
the miR-34 family may have a less prominent role in sheep
heart responses to infarction compared to other mammals. One
miRNA (miR-2313) was uniquely up-regulated in the adolescent
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FIGURE 5 | Venn diagram of differentially expressed miRNAs in the Infarct samples compared to Remote samples and Border samples in fetal and adolescent
sheep. n = 3 per age group. Only miRNAs that were significantly upregulated or downregulated are shown (P < 0.05).
Infarct samples compared to Remote samples. This miRNA
was discovered in the bovine genome, and possible human
homologs, which may represent a potential target for inhibition
after infarction. Since the microarray contained probes from
multiple species for the same miRNA, four miRNAs appeared
to be both up-regulated and down-regulated in both the fetuses
and lambs, this was an artifact of the multispecies redundancy
likely due to slightly different seed sequences between species
leading to inconsistent binding of the miRNAs to the probes.
Since the direction of change was inconclusive, these miRNAs
were not investigated further. Several miRNAs were oppositely
regulated in each age group. Of particular interest were three
miRNAs that were significantly up-regulated in the adolescent
Infarct, but were down-regulated in the fetal Infarct (miR-1538,
miR-558, and miR-150). miR-150 was previously investigated
for its role in cancer metastasis (Wang et al., 2015; Li et al.,
2016; Sun et al., 2016), pulmonary hypertension (Li et al.,
2019) and B cell development (Zhou et al., 2007). mRNA
targets of these three miRNAs (miR-150, miR-558, and miR-
1538) were predicted using miRWalk, and gene ontology was
performed to determine if the miRNAs may be involved in
regulating functions that could be important in cardiac repair.
Given that miRNAs have hundreds of potential target genes,
identifying target pathways rather than specific genes allows a
better overview of the potential role of miRNAs. KEGG pathway
terms for predicted target mRNAs of miR-558 included AMPK
Signaling pathway (P = 4.5E-07), Axon guidance (P = 3.97E-06),
Pathways in cancer (P = 8.93E-05), PI3K-Akt signaling pathway
(P = 0.0014) and HIF-1 Signaling pathway (P = 0.004). KEGG
pathway terms for predicted target mRNAs of miR-1538 included
Circadian entrainment (P = 7.63E-08), ErbB signaling pathway
(P = 6.60E-08), VEGF signaling pathway (P = 1.30E-04), and
several “Cancer” pathways synonymous with cell proliferation.
H9c2 Cell Culture Analysis
Novel miRNA targets for treatment of cardiovascular disease
were identified from the microarray data; these included miR-
150, miR-558, and miR-1538, which were investigated further
by their inhibition in cell culture. H9c2 cardiomyoblasts were
cultured with anti-miRNAs for three miRNAs of interest (miR-
558, miR-1538, and miR-150) as well as a negative control
for a miRNA sequence not expressed in mammals (NC5;
Integrated DNA Technologies, United States). Cell proliferation
was measured in live and fixed cells using a colorimetric
MTS assay and anti-Aurora-B (a marker of cells entering
cytokinesis) immunohistochemistry staining, respectively. miR-
558 inhibition caused an increase (P < 0.05) in cardiomyoblast
proliferation under the “Normoxia,” “Normoxia, Low Glucose,”
and “Hypoxia” conditions using both the MTS assay and
Aurora-B staining (Figures 6, 7). miR-1538 inhibition caused
an increase (P < 0.05) in cell proliferation under “Normoxia,”
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FIGURE 6 | Aurora B immunohistochemistry staining. Representative micrographs of Aurora B immunohistochemistry staining (marker of cells entering cytokinesis)
of H9c2 cardiomyoblasts after treatment with Hypoxia (1% O2). (A) Example of midbody staining in cells undergoing cytokinesis. (B) Negative control miRNA.
(C) miR-558 inhibitor. Arrows indicate positive staining.
FIGURE 7 | Cell proliferation measures. (A) MTS cell proliferation assay. Background corrected proliferation assay absorbance of test anti-miRNAs. (B) % DAB
Positive cells stained using an anti-Aurora-B antibody in 80 counting frames (Negative Control anti-miRNA, anti-miR-558, anti-miR-1538, anti-miR-150) on H9c2
cardiomyoblasts under Normoxia/Hypoxia or Glucose/Low Glucose conditions. *Represents significantly different data from the Negative Control miR group
(P < 0.05). Nx, normoxia; LG, low glucose; Hx, hypoxia. Mean ± Standard Deviation.
and “Hypoxia” conditions using both MTS assay and Aurora-
B staining. miR-150 inhibition was least effective in promoting
proliferation, only increasing cell proliferation (P < 0.05) using
the MTS assay in “Normoxia.” The expression of predicted target
mRNAs for miR-558 and miR-1538 included PAPPA, JAG, NF2,
MYOC1, and SOX4. NF2 was unchanged in response to miRNA
inhibition (Figure 8). This could be due to a false-positive in
the mRNA target prediction. miR-558 inhibition resulted in an
increase in expression of PAPPA in “Normoxia, Low Glucose,”
MYOC1 in “Normoxia” and “Hypoxia,” JAG in “Normoxia,
Low Glucose,” and SOX4 in the “Hypoxia” and “Hypoxia, Low
Glucose” conditions (Figures 8, 9; P < 0.05). miR-1538 inhibition
resulted in an increase in expression of PAPPA in “Normoxia,”
MYOC1 in “Normoxia” and “Hypoxia,” JAG in “Normoxia,
Low Glucose,” and SOX4 in the “Hypoxia” and “Hypoxia, Low
Glucose” conditions (Figures 8, 9; P < 0.05). miR-150 inhibition
increased the expression of only MYOC1 in “Normoxia” and
“Hypoxia” conditions (Figures 8, 9; P < 0.05). Overall, inhibition
miR-558 and miR-1538 were effective for promoting cell
proliferation in vitro and effectively modulating the expression
of their predicted target mRNAs. Further mRNA targets may be
identified from the differentially regulated miRNAs identified in
the current investigation, and additional testing of these miRNAs
on adult differentiated primary cardiomyocytes may provide
evidence supporting enhanced cardiomyocyte proliferation in
large animals at this age.
DISCUSSION
The predicted target mRNA term enrichments for miRNAs
that were up-regulated or down-regulated in Infarct compared
to Remote samples included a number of biological themes
that could be associated with cardiac repair and regeneration.
Common themes comprised cancer-related terms (may reflect
increased cell proliferation), inflammatory cell/leukocyte
migration (inflammation), protein transport and ubiquitination,
MAPK signaling, and WNT signaling. Since it was not possible
to perform target prediction against a cardiac-only background
in miRWalk, there was an absence of muscle related enrichment
terms. A number of these themes were present at both ages in
response to infarction, indicating that a large number of pathways
are similarly regulated in the regenerative and quiescent heart.
Recent evidence by our group and others demonstrated a
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FIGURE 8 | Target gene expression of anti-miRNAs. Mean normalized expression (MNE) of predicted target genes of anti-miRNAs, PAPPA (A), NF2 (B), JAG (C),
MYOC1 (D), and SOX4 (E) demonstrating successful inhibition of miRNA resulting in decreased inhibition of target mRNAs. *Represents significantly different data
from the negative control group (P < 0.05). n = 4 per treatment group.
Frontiers in Physiology | www.frontiersin.org 15 June 2020 | Volume 11 | Article 614
fphys-11-00614 June 8, 2020 Time: 20:31 # 16
Lock et al. miRNA Expression After Sheep MI
FIGURE 9 | Linear regression of PAPPA and MYOC1 expression against measures of proliferation. Mean normalized expression of predicted target genes of
anti-miRNAs against MTS and Aurora B proliferation measures demonstrating effectiveness of miRNA treatments within each oxygen environment.
largely similar but highly attenuated gene expression response to
infarction in the regenerative heart compared to the quiescent
heart (Zgheib et al., 2014; Mills et al., 2017; Quaife-Ryan et al.,
2017; Lock et al., 2019). This response indicates a “resistance” to
damage in the regenerative heart and is supported by the similar
enrichment terms of predicted targets from deregulated miRNAs
after infarction, as demonstrated in this study (Supplementary
File 2). In addition, some similar themes between fetal and
adolescent sheep may be due to the nature of miRNAs targeting a
number of mRNAs, false positives in the mRNA target prediction
method, as well as gene pathway enrichments including both
promotors and repressors of pathways. These factors may lead
to a large number of similar pathway enrichments at both ages.
Limiting the term enrichments to miRNAs that were exclusively
up-regulated or down-regulated at each age helped tease apart the
molecular mechanisms underpinning the proliferative capacity
or lack thereof in fetuses and adolescent hearts, respectively.
Some of the pathways that are targeted by the identified uniquely
deregulated miRNAs within this study are discussed below and
how they may be exploited to improve cardiac regeneration.
Uniquely Deregulated Term Enrichments
FoxO Signaling
Forkhead box (Fox) family transcription factors have been
implicated in cardiomyocyte cell cycle control as well as adult
cardiovascular disease (Ronnebaum and Patterson, 2010). FoxO
signaling was predicted to be oppositely regulated in the fetuses
and adolescent sheep based on the miRNA target genes. miRNAs
that suppress FoxO mRNA were up-regulated in the fetuses
resulting in a decrease in FoxO expression in response to
infarction, compared with an opposing decrease in miRNA
expression in the adolescent sheep consistent with an increase
in FoxO expression. Decreased FoxO activity in the proliferative
fetal heart is a logical outcome given that FoxO is a major negative
regulator of cardiomyocyte proliferation in fetal life. Forced
expression of FoxO inhibits rat cardiomyocyte cell proliferation
and induces expression of cell cycle inhibitors p21 and p27
(Sengupta et al., 2013). In the adult rat heart, activation of FoxO
promotes cardiomyocyte survival under conditions of oxidative
stress and is linked to AMPK and IGF signaling (Ronnebaum
and Patterson, 2010), as well as many other pathways that
were also significantly enriched in this study (endoplasmic
reticulum stress, autophagy, mitochondrial fission, and cell cycle).
FoxO therefore represents an interesting intermediary target
pathway for miRNA inhibition to improve the repair response
after infarction. However, there are a number of challenges
associated with targeting specific isoforms of FoxO (FOXO1 and
FOXO3) as well as differing effects within different cell types
of the heart (Sengupta et al., 2013; Li et al., 2016). This would
likely be an ongoing issue when utilizing miRNAs to target
expression of this pathway as there would be probable cross-
over suppression of both isoforms of FOXO as indicated by the
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predicted target mRNAs (from the fetal up-regulated miRNAs;
miR-6337, miR-1197, miR-125b, miR-24, miR-1, miR-1285, miR-
140, miR-221, miR-222, and miR-411b all have predicted targets
in the FoxO pathway).
Wnt Signaling Pathway
In the current investigation, the Wnt Signaling and Canonical
Wnt signaling pathways were both consistently regulated
pathways by a large number of the differentially regulated
miRNAs. The Wnt pathway has been an area of interest in recent
years for cardiac disease due to its demonstrated role in the
regeneration of cardiac tissue (and other organs such as bone
marrow, intestines and skin) in small animal models (Lock et al.,
2018). The data from the current investigation and other data
suggests that this may be one of the pivotal pathways being
regulated during cardiac repair and regeneration (Mills et al.,
2017; Quaife-Ryan et al., 2017). Three Wnt signaling pathways
have been characterized: (i) the canonical Wnt pathway, (ii) the
non-canonical planar cell polarity (PCP) pathway, and (iii) the
non-canonical Wnt/calcium pathway. These pathways each have
differing transcription factors and target genes but are linked by
the binding of a Wnt-protein ligand to a Frizzled family receptor
on the plasma membrane, which interacts with the intracellular
Disheveled protein. Wnt target genes are modulated through a
number of mechanisms, with the central Wnt signaling proteins
linking multiple important molecular pathways in cardiomyocyte
proliferation and survival such as the Hippo and MAPK pathways
(Lock et al., 2018). Of particular interest were miR-6337, miR-
1197, miR-24, miR-25, miR-125b, miR-29b, miR-1285, miR-
486, and miR-222, all of which were up-regulated in the fetal
Infarct compared to Remote samples and had predicted targets
in the Wnt signaling pathways. Further investigation of the
specific deregulated miRNAs that target this pathway could
cause transient modulation of this powerful signaling cascade
and potentially alter the proliferative ability of cardiomyocytes
after infarction.
Sphingolipid Signaling
Sphingolipid signaling pathway was significantly enriched for a
number of the deregulated miRNAs. Sphingolipids are derivatives
of the amino alcohol sphingosine and are active components
of the cardiomyocytes cell membrane, which play an important
role in intracellular signal transduction and regulate diverse
cellular processes such as proliferation, maturation, apoptosis
and the cellular stress response (Borodzicz et al., 2015). The most
important sphingolipids include ceramide (CER), sphingosine
(SPH), and sphingosine-1-phosphate (S1P). Some proteins such
as tumor necrosis factor-α [TNF-α; which was down-regulated
in the fetal Infarct samples compared to Remote samples and
up-regulated in the adolescent Infarct samples compared to
Remote and Sham samples (Lock et al., 2019)] induce synthesis
of CER from sphingomyelin via sphingomyelinase. CER can
then act as a second messenger, promoting the apoptosis of
cardiomyocytes (Borodzicz et al., 2015). On the other hand,
sphingosine-1-phosphate is cardioprotective (Jin et al., 2002;
Knapp et al., 2012a; Karliner, 2013). The ratio of CER and S1P is
particularly important for control of apoptosis of cardiomyocytes
in the remote area of the myocardium after MI (Knapp et al.,
2012b). miRNA regulation of the proteins involved in the
synthesis and signaling cascade of sphingolipids appears to be
important for their regulation following MI. In particular, let-
7e, miR-6391, miR-378g, miR-4454, miR-671, miR-145, miR-574,
miR-2411, miR-558, and miR-1538 were all down-regulated in
the fetal Infarct compared to Remote samples and contained
predicted mRNA targets within the sphingolipid signaling
pathway. Further investigation of this signaling pathway may
therefore allow for control of apoptosis in the non-infarcted areas
of the heart after heart attack, mitigating cardiomyocyte loss and
subsequent pathological hypertrophy.
Neurotrophin Signaling
The neurotrophin pathway was also significantly enriched for
predicted mRNA targets of oppositely regulated miRNAs at both
ages. Interestingly, brain derived neurotrophic factor (BDNF)
has a cardioprotective role in the heart after infarction by
preventing adverse remodeling, and acts on endothelial cells
to promote neovascularization in response to hypoxic stimuli
via the Akt pathway (Okada et al., 2012). From the miRNAs
that were down-regulated in the fetus and were up-regulated
in the adolescent sheep; let-7e and miR-6391 were of particular
interest in the regulation of the neurotrophin signaling pathway
as they had a large number of predicted target genes within
this pathway (Supplementary File 2). Inhibition of these
miRNAs may therefore help prevent adverse tissue remodeling
after heart attack.
Cardiac Fibrosis
Regulation of cardiac fibrosis and extracellular matrix deposition
following infarction is crucial to maintain contractile function
of the ventricles and prevent ventricular rupture (Sattler and
Rosenthal, 2016). We previously reported increased percentage
of staining of picrosirius red in the Infarcted samples compared
with Sham samples for both age groups (Lock et al., 2019),
but that the localization of the staining was different between
the two age groups (the fetal sheep had larger deposition of
collagen in the Border-zone than the Infarct area). COL1A1
is the major component of type 1 collagen forming a large
portion of the extracellular matrix (Pauschinger et al., 1998).
We have also previously reported that there was an opposite
expression profile between fetuses and adolescent sheep for both
the collagen genes COL1A1 and COL3A1 between the individual
tissue regions, indicating a reciprocal relationship between the
two collagen types in response to infarction (Lock et al., 2019).
This difference of collagen type following infarction is important
as these collagen fibers maintain different elasticity, stiffness and
capacity for degradation by metalloproteinases (MMPs) and is
therefore likely one of the aspects of the fetal heart that allows for
its regeneration. Although this scar formation allows for higher
survival rates after infarction, the diminished contractile ability of
the scar tissue has detrimental effects on long term heart function
leading to chronic heart disease (AIHW, 2015). Interestingly,
there was an up-regulation of miRNAs in the adolescent Infarct
samples that had predicted mRNA targets involved in collagen
fibril organization (miR-25, miR-3535, miR-6391) indicating a
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down-regulation of collagen organization within the adolescent
Infarct samples. Another miRNA of interest was miR-26, which
was down-regulated in the adolescent Infarct samples and plays
a major role in the regulation of cardiac collagen I expression
(Zheng et al., 2018). The observed decrease in miR-26 expression
may help explain the increased expression of COL1A1 in the
adolescent Infarct samples and represents a valuable molecular
target for up-regulation to prevent adverse cardiac fibrosis and
reduce infarct size post-infarct setting in adults.
Potential Targets for miRNA Therapeutic
Inhibition
The current investigation identified 10 miRNAs that were
oppositely regulated in fetuses and adolescent sheep and the effect
of inhibition of these miRNAs on cardiomyocyte proliferation
was then assessed in vitro. Inhibiting miR-558 and miR-1538
was effective for increasing the expression of their target
mRNAs and increasing the number of cells within the cell
cycle in H9c2 cultured cells. SOX4 was only increased in the
hypoxia anti-miRNA treatment groups, which is likely due to
hypoxia-inducible factors (HIF1A and HIF3A) being amongst
the predicted targets for miR-558 and miR-1538. SOX4 most
likely has a hypoxia response element within its promotor region,
resulting in an up-regulation in gene expression only in the
hypoxia anti-miRNA treatment groups (Yeh et al., 2013). One
limitation of this cell culture approach is that the anti-miRNA
treatments were tested in an immortal cardiomyoblast cell line,
which already has a high rate of proliferation. Through this
study, we identified unique miRNAs in sheep and were able to
successfully inhibit these miRNAs in rat cardiomyoblasts, thereby
demonstrating the potential translational capacity of miRNAs
as a treatment between species. Further studies inhibiting these
miRNAs in vivo will determine if this treatment has the capacity
to improve the cardiovascular outcomes and reduce scar tissue
formation after myocardial infarction, and may prove to be
a powerful clinical intervention for transient changes in gene
expression helping prevent the onset of chronic heart disease.
CONCLUSION
Through investigating cardiac regeneration in fetal sheep, we
have identified potential miRNA therapeutics for cardiovascular
disease. Though the translational capacity and high throughput
benefits of small animal experiments is clear, further investigation
of therapeutics using large animal models, such as sheep and
pigs, will help bridge the physiological gap, and allows for
identification of additional unique targets for investigation.
Delivery of miRNAs specifically to the heart remains a significant
challenge for translation to clinical use, some studies have
demonstrated success with intravenous delivery; however, to
avoid potential off-target effects, intracardiac delivery is the
current preferred in vivo delivery method. Although it was not
possible to assess subtle sex specific effects within this study, our
data suggests no effect of sex. This is apparent in the PCA plot
where the fetal Remote samples were virtually super-imposable
and contained two male and one female sample. In addition, our
previous studies using this model demonstrated no significant
difference between sex for sham or remote samples using gene
array (Lock et al., 2020). However, we recognize that evaluating
the response to infarction in both sexes is clinically important
and will be assessed in future studies. A powerful tool in the
study was the inclusion of the salvageable border zone tissue.
This tissue is the first site in which cardiomyocyte proliferation
begins in mammals capable of regeneration (Herdrich et al.,
2010; Porrello et al., 2011; Zgheib et al., 2014), and thus
important changes within this region may be missed in studies
measuring expression on only the infarct and healthy tissue
regions. Predicted mRNA targets of deregulated miRNAs were
most significantly enriched for FoxO, Wnt, and Cardiac Fibrosis
signaling after infarction in the sheep heart. miRNAs and their
targets are often conserved between species, hence targeting these
pathways through modulation of identified uniquely deregulated
miRNAs may improve repair of the adult human heart. miR-
558 and miR-1538 were oppositely regulated in the fetal and
adolescent hearts in response to MI. When inhibited in H9c2
cells these miRNAs were both effective targets for increasing cell
proliferation and target gene expression and therefore represent
strong prospective therapeutics to improve cardiac outcomes
post-MI. The next step is to interrogate the efficacy of these
two miRNAs using the same MI sheep model. These miRNAs
may also be useful targets for cardiovascular diseases outside of
MI where an increase in cardiomyocyte proliferation would be
beneficial. One such example is fetuses with intrauterine growth
restriction (IUGR) that have a lower cardiomyocyte endowment
than normally grown fetuses (Botting et al., 2014). The lower
number of cardiomyocytes in IUGR infants leads to pathological
hypertrophy and an increased risk of cardiovascular disease in
later life (Wang et al., 2011; Lock et al., 2017). Modulating the
expression of these miRNAs in damaged hearts allows for a short-
term change in gene expression and may aid in prevention of the
lasting development of chronic heart disease.
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